KOSDAQCosmetics0015N0

Aromatica

₩5,770▲ 2.12%2026-11-18 close
Market Cap
₩72.6B
Turnover
₩400M
Volume
70K
Shares out.
12.6M
PER
11.9×
PBR
1.3×
EPS
₩484
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Overseas Expansion Drives Profit Recovery; Valuation Remains the Hurdle

Aromatica's quarterly sales and operating profit have stayed at higher levels since Q1 2026, led by overseas channels, but full-year 2025 operating profit declined and the high valuation multiple and supply-side factors after listing remain open questions.

  1. 1

    Quarterly sales in Q1 to Q3 2026 were KRW 14 billion, KRW 17.7 billion and KRW 17.1 billion, with operating profit of KRW 1.34 billion, KRW 2.25 billion and KRW 2.06 billion.

  2. 2

    Full-year 2025 sales were KRW 51.2 billion, down 2.7%, and operating profit was KRW 5.14 billion, down 9.1%. The company attributed the decline to upfront investment in overseas distribution, marketing and hiring.

  3. 3

    Overseas sales reached KRW 11.3 billion in H1 2026, up 47.3% and accounting for 35.5% of total sales (provisional disclosure dated August 5, 2026).

  4. 4

    The share price fell 23.13% in one day on November 9, 2026, despite improving results. A Korean small-cap research note pointed to supply factors such as lock-up expiry, but stated the exact cause had not been confirmed.

  5. 5

    The next regular report is the 2026 annual report, and the key checkpoint is whether full-year 2026 sales and operating profit both rise from 2025 levels.

02

Business structure

Aromatica is an aromatherapy-based scalp and skincare brand that uses natural essential oils and in-house extracted ingredients.

The company runs a vertically integrated structure at its Osan plant in Gyeonggi Province, covering raw material sourcing, R&D, manufacturing and sales, which it presents as the basis of its cost competitiveness in an industry heavily reliant on ODM.

Its key products are Rosemary Scalp Scaling Shampoo, Rosemary Root Enhancer, Pure and Soft Feminine Cleanser and Soothing Aloe Vera Gel.

At an November 2025 IPO briefing, the company cited cumulative sales of 4.2 million bottles for Rosemary Scalp Scaling Shampoo and 2.8 million bottles for Pure and Soft Feminine Cleanser, with Rosemary Root Enhancer and Soothing Aloe Vera Gel each above 1 million units.

Based on H1 2025 data reported in the press, Rosemary Scalp Scaling Shampoo accounted for about 10.04% of sales and Rosemary Root Enhancer for about 11.50%. Domestic sales in H1 2026 were KRW 20.5 billion, up 21.8%, and retail channel sales rose 77.4%.

Overseas, Amazon sales in the US rose 109% in H1 2026 and became a core channel. Overseas sales in Q3 2026 were KRW 5.77 billion, up more than 50%, according to a provisional release dated November 6, 2026. In the IPO process, the company named LG H&H, Silic on 2-linked peers...

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3———
2025Q4₩13.7B₩1B7.2%
2026Q1₩14B₩1.3B9.5%
2026Q2₩17.7B₩2.2B12.7%
2026Q3₩17.1B₩2.1B12.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2024₩52.6B₩5.7B₩4.4B10.7%23.7%76.5%
2025₩51.2B₩5.1B₩4.6B10.0%10.8%21.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a disclosed basis, full-year sales fell from KRW 52.6 billion in 2024 to KRW 51.2 billion in 2025, down 2.7%. Operating profit declined from KRW 5.65 billion to KRW 5.14 billion, down 9.1%, and the operating margin narrowed from 10.7% to 10.0%.

Profit attributable to controlling shareholders rose from KRW 4.43 billion to KRW 4.58 billion, up 3.4%, while net profit including non-controlling interests moved in the same way over the same period. The press attributed the net profit improvement despite lower operating profit to lower non-operating expenses.

The sales decline reflected temporary sales adjustments during a portfolio reshuffle toward overseas markets in H1 2025. The operating profit decline was linked to short-term costs from expanding overseas distribution, marketing and hiring.

According to press reports, Q4 2025 operating profit was KRW 995 million, down 48.9% year on year. Quarterly sales moved from KRW 13.7 billion in Q4 2025 to KRW 14 billion in Q1 2026, with operating profit rising from KRW 995 million to KRW 1.34 billion.

Q2 2026 sales of KRW 17.7 billion rose 26.7% from the prior quarter, and operating profit of KRW 2.25 billion rose 68.2%, the largest sequential gain in the period.

In Q3 2026, sales of KRW 17.1 billion fell 3.5% and operating profit of KRW 2.06 billion fell 8.5% from the prior quarter, while profit attributable to controlling shareholders of KRW 1.63 billion fell 6.9%. Over the last four quarters, profit attributable to controlling shareholders totaled KRW 5.9 billion.

Operating cash flow fell from KRW 7.91 billion in 2024 to KRW 5.1 billion in 2025, moving in the opposite direction from net profit.

05

Industry analysis

In the cosmetics industry, scalp and hair care is seen as an area extending beyond skincare, in line with the skinification trend. At its November 2025 IPO briefing, the company's CEO said the importance of scalp care is rising and expects the global scalp care market to grow at an annual rate of 6.9% through 2033.

A beauty industry official described K-beauty as expanding from basic skincare toward hair and wellness. On demand, the company said Rosemary Root Enhancer ranked first in Italy, second in Germany and third in the US on Amazon during the Q4 2025 Black Friday and Cyber Monday period.

These are platform rankings reported by the company rather than independently verified market share data. On regulation, the company said it is preparing for European export by removing silicone oils and raising the share of recycled materials.

Against domestic ODM-based competitors, the company positions its direct sourcing-to-production model as a differentiator. The market has cited APR as a bellwether in the sector, and press reports said Aromatica's valuation burden stands out more in comparison with that stock.

The peers the company named in its IPO, including LG H&H, It's Hanbul and VT, differ in scale and channel structure, so shelf position at overseas distributors and platforms is likely to be a key variable.

06

Outlook

The company set a 2026 goal of returning both sales and profit to positive growth. Provisional results showed H1 2026 sales of KRW 31.7 billion, up 29.8%, and operating profit of KRW 3.6 billion, up 60.1% (released August 5, 2026).

A provisional release on November 6, 2026 showed cumulative January-to-September 2026 sales of KRW 48.9 billion, up 30.5%. The second-half distribution plan centers on overseas expansion.

The company targets about 600 offline stores at Target in the US, and plans to expand overseas store points from 763 at end-2025 and 1,589 at mid-2026 to about 3,000 in the second half. Listings at Ulta Beauty online in North America and 170 offline stores at Rossmann in Eastern Europe were confirmed in H1.

The company plans to open a TikTok Shop in the second half to broaden online sales, and to launch channel-specific limited products around Black Friday and year-end promotions in Q4. As a medium-term goal set during its IPO in November 2025, the company aims for overseas sales above 50% of the total by 2027.

Facility funds will go to domestic store expansion, a global direct-to-consumer site, logistics infrastructure and warehouse property, to be spent in stages during 2026 and 2027. These are company plans, and their execution will be checked in later periodic and quarterly filings.

07

Valuation

PER
11.9×
PBR
1.3×
ROE
17.0%
EPS
₩484
BPS
₩4,551
Dividend per share
₩0

At the IPO, the price-to-earnings ratio at the offer price was reported to be above 20 times. The Stock reported that the multiple burden persists even after reflecting recent earnings. A Korean small-cap research note on November 9, 2026 noted that the price-to-book ratio is not especially low against sector peers.

Relative to net assets, market capitalization is above total equity of KRW 42.5 billion at end-2025, and equity attributable to controlling shareholders is also KRW 42.5 billion.

Against the last four quarters' profit attributable to controlling shareholders of KRW 5.9 billion, market capitalization is high relative to earnings, and whether earnings growth can catch up with the multiple has been identified as the central question.

Press reports said the valuation burden stands out more when compared with APR, which is cited as a sector bellwether. The dividend payout level is below the industry average, so the case for shareholder returns is limited.

Because the multiple depends on the pace of earnings growth relative to share price movement, earnings trends in the next periodic report will serve as the reference point.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Quarterly profit recovery

Quarterly sales from Q1 to Q3 2026 held at KRW 14 billion, KRW 17.7 billion and KRW 17.1 billion, with operating profit of KRW 1.34 billion, KRW 2.25 billion and KRW 2.06 billion. Provisional data showed the H1 2026 cumulative operating margin at 11.3%, up 2.1 percentage points year on year. Bulls point to the change in direction compared with the decline in full-year 2025 operating profit.

Overseas channels and Amazon growth

Overseas sales reached KRW 11.3 billion in H1 2026, up 47.3%, and US Amazon sales rose 109%. Q3 2026 overseas sales were KRW 5.77 billion, up more than 50%, according to a provisional release. Overseas store points rose from 763 at end-2025 to 1,589 at mid-2026, which points to a wider distribution base.

Cost structure built on in-house manufacturing

The vertically integrated structure, from raw material sourcing to manufacturing, is presented as the basis of cost competitiveness against ODM-reliant peers.

The company said its key product, Rosemary Root Enhancer, ranked first in Italy, second in Germany and third in the US on Amazon during the Q4 2025 Black Friday and Cyber Monday period. The scalp care line aligned with the skinification trend is described as the base for expansion.

09

Bear factors

Multiple burden and supply factors

Since listing, the share price has moved apart from improving results. It fell 23.13% in one day on November 9, 2026, though the research note said the exact cause had not been confirmed.

Supply factors such as lock-up expiry remain, and critics point out that the price-to-book ratio is not especially low against peers.

2025 profit decline and cost burden

Press reports said Q4 2025 operating profit dropped 48.9% year on year. Because overseas expansion costs weighed on profit in the short term, continued overseas marketing and hiring spending could slow the pace of margin improvement.

Overseas channel and product concentration

A large part of overseas growth depends on sales through Amazon. As of H1 2025, two key products each accounted for more than 10% of sales, so product concentration is high. A shift in demand for a specific product or platform could have a large impact on results.

10

Risk factors

Supply and free float

After the one-day 23.13% decline on November 9, 2026, the lock-up expiry schedule was cited as a key variable. The timing and volume of releases should be checked in the prospectus and shareholding filings. Until the schedule and size are confirmed, the scale of the supply effect is hard to gauge.

Overseas regulation and FX

Compliance with tightening environmental rules in Europe requires removing silicone oils and raising recycled material use. Given the high share of US and Japanese sales, currency movements and changes in local distribution policies could affect won-denominated results.

Channel policy and partner dependence

Overseas growth relies on online platforms such as Amazon and on cooperation with global B2B partners such as Silicon 2. Changes in platform fees or partner policies would directly affect sales and margins. In a competitive domestic cosmetics market, continued reconfiguration of product mixes by channel will be needed.

11

What to watch next

  1. Lock-up expiry date unconfirmed (check prospectus and shareholding filings)

    This checks the timing and volume of lock-up releases cited as a factor behind the November 9, 2026 decline. The size of released shares relative to the free float determines the scale of the supply impact.

  2. December 2026 (after Black Friday and year-end promotions)

    This checks whether Q4 2026 sales, supported by limited products and year-end promotions, exceed KRW 13.7 billion in Q4 2025. It should be read alongside overseas Amazon sales trends.

  3. After December 2026 (listing schedule unconfirmed)

    This checks whether the planned TikTok Shop opening and Target offline listings were carried out. The key question is whether planned store points translate into actual sales.

  4. March 2027 (2026 annual report)

    This checks whether full-year 2026 sales and operating profit both rose from 2025 levels of KRW 51.2 billion and KRW 5.14 billion, and whether the operating margin exceeds 10.0% in 2025.

12

Overall view

Aromatica's full-year 2025 sales and operating profit declined, while profit attributable to controlling shareholders rose, and quarterly sales and operating profit stayed at higher levels from Q1 to Q3 2026.

Growth has been driven by US Amazon and wider overseas offline distribution, and domestic sales also rose with retail channel expansion. Strengths cited include the in-house cost structure, the scalp care category and wider overseas listings.

Weaknesses include the 2025 full-year profit decline and overseas expansion costs, the valuation burden that has been high since listing, and supply factors that remain after the November 9 decline.

The next checkpoint is the 2026 annual report, and whether full-year 2026 operating margin exceeds the 10.0% of 2025 is the benchmark. Confirming the lock-up schedule and execution of second-half distribution plans are also important. This report is for information only and does not include a buy or sell opinion.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. the-stock.kr
  2. ktnews.com
  3. sports.khan.co.kr
  4. zdnet.co.kr
  5. zdnet.co.kr
  6. etoday.co.kr
  7. newsprime.co.kr
  8. beautynury.com
  9. sisamagazine.co.kr
  10. mt.co.kr
  11. company.aromatica.co
  12. zdnet.co.kr
  13. newstopkorea.com
  14. aromatica.co
  15. sports.khan.co.kr
  16. aromatica.co
  17. v.daum.net
  18. m.ekn.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis